SULPIRIDE AUGMENTATION OF ANY ANTIPSYCHOTIC DRUG vs antipsychotics
Global state: 1. General ‐ no clinically significant improvement ‐ short term < 30% improvement on BPRS · patients with schizophrenia
SULPIRIDE AUGMENTATION OF ANY ANTIPSYCHOTIC DRUG showed no clear difference in global state: No clinically important response ‐ short term compared with ANY ANTIPSYCHOTIC DRUG (low certainty).
1 finding from 1 review
- RR 0.58 [0.3, 1.09]3 studies · 193 participantsLow